Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Objective: The goal of this study was to determine the relative frequencies of benign external hydrocephalus (BEH), hydrocephalus and other conditions in a large series of imaging studies performed for macrocephaly and identify additional risk factors for patients with macrocephaly that would most likely benefit from neuroimaging evaluation. Material and Methods: Medical records at our center were searched for the term macrocephaly retrospectively. The search extended from 1th January 2014 to 1th June 2019. Patients older than 36 months of age were excluded. Information about age, gender, symptoms and clinical signs (seizures, neurologic abnormalities on exam such as hypotonia), neuroimaging findings, developmental delay, family history of macrocephaly and head circumference (HC) were collected for each patient. Results: A total of 103 patients were included in the analysis. The mean age at the time of imaging was 9 months (±5.5 months). Twenty-one (20.3%) of the subjects were female and 82 (79.6%) were male. Twenty-nine of the imaging studies were magnetic resonance imaging, 26 were computed tomography and 65 were head ultrasounds. Patients with abnormal neuroimaging results had significantly higher rates of developmental delay or abnormal neurologic exam than patients with normal neuroimaging results or BEH (p=0.003 and p<0.0001). There was no significant difference between the neuroimaging results of patients with and without positive family history of macrocephaly. Conclusion: This study suggests that neuroimaging for macrocephaly has almost negligible diagnostic yield unless having developmental delay or abnormal neurological examination.
Objective: The goal of this study was to determine the relative frequencies of benign external hydrocephalus (BEH), hydrocephalus and other conditions in a large series of imaging studies performed for macrocephaly and identify additional risk factors for patients with macrocephaly that would most likely benefit from neuroimaging evaluation. Material and Methods: Medical records at our center were searched for the term macrocephaly retrospectively. The search extended from 1th January 2014 to 1th June 2019. Patients older than 36 months of age were excluded. Information about age, gender, symptoms and clinical signs (seizures, neurologic abnormalities on exam such as hypotonia), neuroimaging findings, developmental delay, family history of macrocephaly and head circumference (HC) were collected for each patient. Results: A total of 103 patients were included in the analysis. The mean age at the time of imaging was 9 months (±5.5 months). Twenty-one (20.3%) of the subjects were female and 82 (79.6%) were male. Twenty-nine of the imaging studies were magnetic resonance imaging, 26 were computed tomography and 65 were head ultrasounds. Patients with abnormal neuroimaging results had significantly higher rates of developmental delay or abnormal neurologic exam than patients with normal neuroimaging results or BEH (p=0.003 and p<0.0001). There was no significant difference between the neuroimaging results of patients with and without positive family history of macrocephaly. Conclusion: This study suggests that neuroimaging for macrocephaly has almost negligible diagnostic yield unless having developmental delay or abnormal neurological examination.
Dysmorphology is the study of human congenital malformations and combines concepts and knowledge of different medical fields, including embryology and clinical genetics. Syndromology specialises in the diagnosis of multiple congenital anomalies through the recognition of patterns of human malformations. This article provides a theoretical framework of dysmorphism and a clinical and molecular diagnostic approach to the child that presents with a congenital malformation. The assessment of a dysmorphic child must contain a detailed family, prenatal and birth history, an evaluation of the psychomotor development and a good clinical examination, including biometry, neurology and detailed description of minor and major anomalies. Dysmorphic syndromes often present variable phenotypes and may escape clinical diagnosis even when causative molecular defects are similar. Alternatively, locus heterogeneity or mutations in different genes can underlie similar phenotypes. Therefore, technical advances are shifting the field of dysmorphology from gestalt diagnoses to broad molecular diagnostics and reverse phenotyping. Key Concepts Dysmorphism refers to any observable structural abnormality of the body but colloquially is often used to indicate facial dysmorphism. The phenotype refers to the totality of the presentation including facial gestalt, congenital anomalies, psychomotor development and behavioural patterns. Pathognomonic features can be subtle but are very specific for one disorder and confirm a clinical diagnosis. Congenital anomalies are categorized into deformations, disruptions, dysplasias and malformations. Multiple congenital anomalies can be categorized as associations, syndromes or sequences. Continuous technical advances have greatly improved the diagnostic yield of molecular investigations in human malformations. Accurate diagnosis can reduce uncertainty, offer prognostic predictions, allow counselling of recurrence risk and earlier recognition of care needs through screening for additional comorbidities and better follow‐up, and guide therapeutic strategies.
BackgroundMacrocephaly is a clinical observation denoted as an occipitofrontal head circumference exceeding two standard deviations above same age and sex norms. By its definition, macrocephaly occurs in approximately 3% of the population. Descriptive epidemiologic evaluations of macrocephaly are lacking in the literature. The primary objective of this study was to describe the prevalence of macrocephaly captured by the Texas Birth Defects Registry (TBDR) by infant sex, rural/urban residence, and select maternal characteristics.MethodsCases of TBDR between 1999 and 2019 with a six‐digit Centers for Disease Control modified‐British Pediatric Association (BPA) code of 742.400 (enlarged brain/head, large head, macrocephaly, megalencephaly) were identified. All pregnancy outcomes and diagnostic certainties were included. Prevalence (per 10,000 live births) and 95% confidence intervals (CIs) were calculated using a Poisson table by rural/urban residence, infant sex, maternal age, education, race/ethnicity, history of diabetes, and body mass index (BMI). Prevalence calculations were repeated across multiple sensitivity analyses including (1) definite, isolated cases excluding those with indication of being either “benign” or “familial”, (2) definite, non‐isolated cases, (3) definite non‐isolated cases excluding chromosomal and syndromic cases, and (4) definite, proportionate (at birth) cases. A secondary objective was to describe the most common co‐occurring congenital defects among definite, non‐isolated cases.ResultsOverall, between 1999 and 2019, 14,637 cases of macrocephaly were identified in the TBDR resulting in a prevalence of 18.12/10,000 live births (95% CI: 17.83–18.42). Most cases were live born (99%), had a definite diagnosis (87%), and were non‐isolated (57%). Prevalence was significantly higher among males, among those with an urban residence, and among mothers who were older, Non‐Hispanic White, who had greater than high school education, who had a history of diabetes, and who were obese. Prevalence patterns remained consistent across all sensitivity analyses. The most common co‐occurring congenital defects among definite, non‐isolated cases were minor and primarily included skull and facial bone anomalies (e.g., plagiocephaly [18%]).ConclusionsTo our knowledge, this is the first epidemiologic evaluation of macrocephaly in a birth defects registry. The long‐term clinical impact of isolated macrocephaly is not well understood and should be the focus of future investigations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.